Thus, chronically elevated MYC levels may not be able to sustain pro-apoptotic levels of AMPK-BIM activity long-term and it is tempting to speculate that pharmacological stimulation of AMPK reactivates the MYC-associated apoptotic machinery intrinsic to tumor cells (Fig. 3f). Here, BCL2L11 is linked to neoplasm.